AI assistant
ACADIA PHARMACEUTICALS INC — Director's Dealing 2021
Nov 5, 2021
31237_dirs_2021-11-05_40024c28-ff55-4bce-9c16-57acf3ba5d5b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ACADIA PHARMACEUTICALS INC (ACAD)
CIK: 0001070494
Period of Report: 2021-11-01
Reporting Person: Teehan Brendan (EVP, COO, Head of Commercial)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 807 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) | $16.87 | 2028-07-15 | Common Stock (52500) | Direct | |
| Employee Stock Option (Right to Buy) | $25.12 | 2029-04-28 | Common Stock (10993) | Direct | |
| Employee Stock Option (Right to Buy) | $42.81 | 2030-01-05 | Common Stock (9336) | Direct | |
| Employee Stock Option (Right to Buy) | $49.74 | 2031-02-22 | Common Stock (8152) | Direct | |
| Restricted Stock Units | $ | Common Stock (3134) | Direct | ||
| Restricted Stock Units | $ | Common Stock (3859) | Direct | ||
| Restricted Stock Units | $ | Common Stock (4427) | Direct |
Footnotes
F1: 25% of the 70,000 shares originally subject to the stock option vested and became exercisable on July 16, 2019, and the remaining shares vest and become exercisable in 36 equal monthly installments thereafter.
F2: 25% of the shares subject to the Stock Option vested and became exercisable on April 29, 2020, and the remaining shares vest and become exercisable in 36 equal monthly installments thereafter.
F3: 25% of the shares subject to the Stock Option vested and became exercisable on January 6, 2021, and the remaining shares vest and become exercisable in 36 equal monthly installments thereafter.
F4: 25% of the shares subject to the Stock Option vest and become exercisable on February 23, 2022, and the remaining shares vest and become exercisable in 36 equal monthly installments thereafter.
F5: 50% of the shares subject to the restricted stock units vest on each of April 29, 2022 and April 29, 2023.
F6: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F7: One-third of the shares subject to the restricted stock units vest on each of January 6, 2022, January 6, 2023 and January 6, 2024.
F8: The restricted stock units vest in four equal annual installments beginning February 23, 2022.